Adjuvant Holdings Co.,Ltd. (TYO:4929)

Adjuvant Holdings Revenue

In the fiscal year ending March 20, 2026, Adjuvant Holdings had annual revenue of 3.81B JPY, down -6.95%. Adjuvant Holdings had revenue of 692.00M in the quarter ending March 20, 2026, a decrease of -18.40%.

• Revenue: 3.81B
• Revenue Growth: -6.95%
• P/S Ratio: 1.56
• Revenue / Employee: 30.75M
• Employees: 124
• Market Cap: 5.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 20, 2026	3.81B	-285.00M	-6.95%
Mar 20, 2025	4.10B	-340.00M	-7.66%
Mar 20, 2024	4.44B	61.00M	1.39%
Mar 20, 2023	4.38B	-50.00M	-1.13%
Mar 20, 2022	4.43B	-458.00M	-9.38%

Data Source: S&P Global Market Intelligence Last updated: Mar 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 7, 2026

Data Sources Report a data error